Posts for Ticker ‘Biodel’

Biodel Trades Down Close To Net Asset Value (BIOD)

If you just read headlines on Biodel Inc. (Nasdaq: BIOD) this morning, you would have thought the news coming out of the company was either good or just neutral.  Today was the exact opposite, and was an example of how dangerous it can be in merely glancing over data in biotech and emerging drug companies.  Biodel’s pivotal Phase III trials for VIAject met the primary endpoint of non-inferiority and results which demonstrated statistically significant reductions in hypoglycemic events and weight gain in Type 1 and 2 diabetes patients.  But there are problems with the data which were confusing.

Read More »

Posted on: September 8, 2008 – 3:55 pm in Biotech, Drug companies, , , , ,